Divalproex Sodium Capsule, Coated Pellets
Product Images NDC 70518-1749

6 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 70518-1749). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Divalproex (Ffa6763e F2cd 447c B174 684e10c57488 01)

Structured Product Formula For Divalproex (Ffa6763e F2cd 447c B174 684e10c57488 01)
Chemical structure of divalproex sodium showing the molecular arrangement of its components, including sodium ions and branched alkyl chains.*
FDA Label Image

Structured Product Formula For Divalproex (Ffa6763e F2cd 447c B174 684e10c57488 02)

Structured Product Formula For Divalproex (Ffa6763e F2cd 447c B174 684e10c57488 02)
A cumulative distribution plot comparing the percentage reduction in CPS (Clinical Parameter Score) rate for patients treated with divalproex sodium delayed-release tablets versus placebo. The x-axis represents the percentage of patients from 100 to 0, and the y-axis represents the percentage reduction in CPS rate from -100% (worsening) to 100% (improvement). The solid line shows the divalproex sodium effect, and the dashed line shows the placebo effect.*
FDA Label Image

Structured Product Formula For Divalproex (Ffa6763e F2cd 447c B174 684e10c57488 03)

Structured Product Formula For Divalproex (Ffa6763e F2cd 447c B174 684e10c57488 03)
A chart showing the percentage reduction in CPS rate versus percentage of patients, comparing high dose (solid line) and low dose (dashed line) groups. The vertical axis shows improvement and worsening, with a zero change line, and the horizontal axis represents the percentage of patients from 100 to 0.*
FDA Label Image

Divalproex Sprinkle Capsule (Ffa6763e F2cd 447c B174 684e10c57488 04)

Divalproex Sprinkle Capsule (Ffa6763e F2cd 447c B174 684e10c57488 04)
An instructional diagram showing five steps for administering divalproex sodium delayed-release capsules by mixing their contents into soft food before swallowing. The images illustrate placing soft food in a cup or bowl, carefully handling and opening the capsule, emptying its contents into the food, stirring, and swallowing the mixture with water.*
FDA Label Image

Mm1 (Divalproex Sodium 125mg 70518 1749 00)

Mm1 (Divalproex Sodium 125mg 70518 1749 00)
Label for Divalproex Sodium 125 mg delayed-release sprinkle capsule, quantity 1, repackaged by RemedyRepack Inc. It includes the NDC number 70518-1749-00 and manufacturer Zydus Pharm, Pennington, NJ. Directions reference the package insert, with storage temperature guidance provided.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for divalproex sodium delayed-release capsules, 125 mg strength, in a quantity of 100 capsules. The label indicates the product is for oral use with a sprinkle formulation. Manufactured by Zydus Pharm, repackaged by RemedyRepack Inc. Includes NDC 70518-1749-01 and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.